(0.91%) 5 064.20 points
(0.85%) 38 226 points
(1.51%) 15 841 points
(0.24%) $79.14
(0.05%) $2.04
(0.19%) $2 314.10
(0.45%) $26.95
(0.11%) $963.70
(-0.13%) $0.932
(-0.45%) $10.98
(-0.12%) $0.798
(-2.29%) $91.12
Quarter results today
(bmo 2024-05-02)
Expected move: +/- 10.96%
@ $126.56
Išleistas: 2 geg. 2024 @ 22:25
Grąža: -0.76%
Ankstesnis signalas: geg. 2 - 16:30
Ankstesnis signalas:
Grąža: 9.45 %
Live Chart Being Loaded With Signals
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally...
Stats | |
---|---|
Šios dienos apimtis | 11.87M |
Vidutinė apimtis | 3.79M |
Rinkos kapitalizacija | 48.09B |
EPS | $0 ( 2024-02-22 ) |
Kita pelno data | ( $0 ) 2024-08-01 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -10.19 |
ATR14 | $14.67 (11.72%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-24 | Afeyan Noubar | Sell | 3 926 | Common Stock |
2024-04-24 | Afeyan Noubar | Sell | 5 821 | Common Stock |
2024-04-24 | Afeyan Noubar | Sell | 4 153 | Common Stock |
2024-04-24 | Afeyan Noubar | Sell | 1 100 | Common Stock |
2024-04-17 | Afeyan Noubar | Sell | 8 243 | Common Stock |
INSIDER POWER |
---|
31.12 |
Last 100 transactions |
Buy: 525 652 | Sell: 274 802 |
Tūris Koreliacija
Moderna Inc Koreliacija
10 Labiausiai teigiamai susiję koreliacijos |
---|
10 Labiausiai neigiamai susiję koreliacijos |
---|
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
Moderna Inc Koreliacija - Valiuta/Žaliavos
Moderna Inc Finansinės ataskaitos
Annual | 2023 |
Pajamos: | $6.75B |
Bruto pelnas: | $2.06B (30.52 %) |
EPS: | $-12.34 |
FY | 2023 |
Pajamos: | $6.75B |
Bruto pelnas: | $2.06B (30.52 %) |
EPS: | $-12.34 |
FY | 2022 |
Pajamos: | $19.26B |
Bruto pelnas: | $13.85B (71.88 %) |
EPS: | $21.22 |
FY | 2021 |
Pajamos: | $18.47B |
Bruto pelnas: | $15.85B (85.83 %) |
EPS: | $30.31 |
Financial Reports:
No articles found.
Moderna Inc
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, respiratory syncytial virus, Endemic HCoV, and hMPV+PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, human immunodeficiency virus, herpes simplex virus, and varicella-zoster virus vaccines; and public health vaccines consists of Zika and Nipah vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; localized regenerative, systemic intracellular, and inhaled pulmonary therapeutics. It has strategic alliances with AstraZeneca PLC; Merck & Co., Inc.; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Carisma Therapeutics, Inc.; Metagenomi, Inc.; the Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; and The Bill & Melinda Gates Foundation, as well as a collaboration and license agreement with Chiesi Farmaceutici S.P.A. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.